AdaptHealth Reports Q3 2026 Revenue Growth and Raises Full-Year Guidance
AdaptHealth (AHCO) reported third-quarter net revenue of $745.6 million, a 10.9% increase year-over-year, driven largely by organic growth and strong performance in its Sleep Health segment. Despite the top-line growth, the company reported a net loss of $168.2 million due to a significant $184.8 million non-cash goodwill impairment charge resulting from declining equity market capitalization. Management raised its full-year revenue guidance to a range of $2.88 billion to $2.90 billion and increased its adjusted EBITDA outlook to $510 million–$525 million. The company is also progressing toward the sale of its Diabetes Health unit for $235 million, expected to close in early 2027. While labor costs remain high on its largest capitated contract, margins for that specific contract improved sequentially from -4% to 10%.
Tickers: $AHCO
Topics: Asset Sale Goodwill Impairment Net Loss Revenue Growth Segment Performance